Arvinas Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include NextCure.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | |
Founding Date | Founding Date 2016 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Beltsville, US HQ |
Employees | Employees 1123% decrease | Employees N/A |
Valuation ($) | Valuation ($) 452 m | Valuation ($) 39.2 m |
Financial | ||
Net income | Net income ($74.4m) (FY, 2025) | Net income ($55.8m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 160m |
For sources of this data, please see the company profile
View Company Profiles
NextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company